Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard W Price

Showing results (61-70 of 148) with videos related to

Pageof 15
Sort By:
Journal of Neuroinflammation|May 14, 2013
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapyAylin Yilmaz, Constantin T Yiannoutsos, Dietmar Fuchs, et al.
BMC Neurology|May 27, 2022
Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infectionBirgitta Anesten, Henrik Zetterberg, Staffan Nilsson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 26, 2008
Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infectionElizabeth Sinclair, Rollie Ronquillo, Nicole Lollo, et al.
Acta Neurologica Belgica|February 3, 2010
Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serumDiego Franciotta, Arabella Bestetti, Serena Sala, et al.
The Journal of Infectious Diseases|February 18, 2005
HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremiaSerena S Spudich, Wei Huang, Annelie C Nilsson, et al.
The Journal of Infectious Diseases|June 8, 2004
Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infectionBarbara L Shacklett, Catherine A Cox, David T Wilkens, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2005
T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infectionJutta K Neuenburg, Tracey A Cho, Annelie Nilsson, et al.
Plos One|February 14, 2014
Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patientsJan Jessen Krut, Tomas Mellberg, Richard W Price, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2018
Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus InfectionRyan Sanford, Beau M Ances, Dieter J Meyerhoff, et al.
Virulence|July 21, 2016
No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau)Jan J Krut, Richard W Price, Henrik Zetterberg, et al.
Pageof 15

Showing results (61-70 of 148) with videos related to

Sort By:
Pageof 15
Journal of Neuroinflammation|May 14, 2013
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapyAylin Yilmaz, Constantin T Yiannoutsos, Dietmar Fuchs, et al.
BMC Neurology|May 27, 2022
Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infectionBirgitta Anesten, Henrik Zetterberg, Staffan Nilsson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 26, 2008
Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infectionElizabeth Sinclair, Rollie Ronquillo, Nicole Lollo, et al.
Acta Neurologica Belgica|February 3, 2010
Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serumDiego Franciotta, Arabella Bestetti, Serena Sala, et al.
The Journal of Infectious Diseases|February 18, 2005
HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremiaSerena S Spudich, Wei Huang, Annelie C Nilsson, et al.
The Journal of Infectious Diseases|June 8, 2004
Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infectionBarbara L Shacklett, Catherine A Cox, David T Wilkens, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2005
T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infectionJutta K Neuenburg, Tracey A Cho, Annelie Nilsson, et al.
Plos One|February 14, 2014
Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patientsJan Jessen Krut, Tomas Mellberg, Richard W Price, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2018
Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus InfectionRyan Sanford, Beau M Ances, Dieter J Meyerhoff, et al.
Virulence|July 21, 2016
No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau)Jan J Krut, Richard W Price, Henrik Zetterberg, et al.
Pageof 15